Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Jazz Pharmaceuticals plc - Ordinary Shares (NQ:JAZZ)

172.59 -0.66 (-0.38%)
Streaming Delayed Price Updated: 12:38 PM EST, Feb 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Jazz Pharmaceuticals plc - Ordinary Shares

< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
News headline image
After Jumping 100%, Is Axsome a Buy Before 2023? ↗
Axsome's revenue story is just getting started. 
Via The Motley Fool
News headline image
Netflix To Rally Around 29%? Here Are 10 Other Price Target Changes For Friday ↗
Wells Fargo raised Netflix, Inc. (NASDAQ: NFLX) price target from $300 to $400. Wells Fargo also upgraded the stock from Equal Weight to Overweight. Netflix shares rose 0.6% to close at $310.26 on... 
Via Benzinga
6 Analysts Have This to Say About Jazz Pharmaceuticals ↗
 
Via Benzinga
What 6 Analyst Ratings Have To Say About Jazz Pharmaceuticals ↗
 
Via Benzinga
News headline image
2 Unstoppable Growth Stocks to Buy in 2022 and Beyond ↗
These biotech players beat the bear market this year. 
Via The Motley Fool
News headline image
3 Fierce Stocks That Are Screaming Buys in December ↗
Here are three winners in the making. 
Via The Motley Fool
News headline image
Is Axsome Therapeutics Stock a Buy Now? ↗
The company seems to be coming into its own. 
Via The Motley Fool
News headline image
Why Shares of Zymeworks Rose 12.18% on Monday ↗
The biotech stock's shares may have been pushed by a short squeeze. 
Via The Motley Fool
News headline image
Why Zymeworks Stock Is Soaring Today ↗
Investors applauded a major licensing deal with Jazz Pharmaceuticals. 
Via The Motley Fool
News headline image
Jazz Caregiver Survey: CBD-Based Epidiolex Improves Seizure & Non-Seizure Outcomes In Patients With Severe Epilepsy ↗
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) announced new real-world data from the BECOME (BEhavior, COgnition, and More with Epidiolex) caregiver survey that showed a substantial proportion of caregivers... 
Via Benzinga
News headline image
Biotech Space Offers Reward In 2023 Despite Economic Risks ↗
Despite the economic headwinds, the mid-to long-term outlook for the biotech space remains strong, and investors who are able to take advantage of undervalued biotech stocks may be well-positioned for... 
Via Talk Markets
News headline image
Q3 Proves To Be Another Tough Quarter For Cannabis ↗
It’s been a tough year for cannabis investors and Q3 offered little relief. 
Via Talk Markets
News headline image
Goldman Sachs, Walmart And These 2 Stocks Insiders Are Selling ↗
The Nasdaq Composite dropped around 0.5% on Friday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
News headline image
Want to Double Your Money? Buying These Stocks Could be a Genius Move ↗
These stocks are undervalued considering their long-term growth potential. 
Via The Motley Fool
News headline image
Prediction: This Growth Stock Could Double in 2023 ↗
The next year should be a busy one for this drugmaker. 
Via The Motley Fool
News headline image
Analyst Bumps Up Price Target For Avadel Pharmaceuticals After Favorable Patent Ruling ↗
Last Friday, Delaware District Court granted Avadel Pharmaceuticals plc's (NASDAQ: AVDL) motion to delist the ‘963 Xyrem REMS patent. 
Via Benzinga
News headline image
Avadel Pharmaceuticals Announces Favorable Ruling Regarding Sleep Disorder Drug Patent ↗
 
Via Benzinga
News headline image
Got $500? 3 Growth Stocks to Buy That Could Double Your Money ↗
Innovative products and services could keep these companies growing. 
Via The Motley Fool
News headline image
3 Top Cannabis Stocks to Buy in November ↗
These solid performers are managing to grow revenue in a difficult environment. 
Via The Motley Fool
News headline image
2 Dirt Cheap Growth Stocks to Buy and Hold for Years ↗
In the long run, these stocks could deliver great returns. 
Via The Motley Fool
News headline image
What 5 Analyst Ratings Have To Say About Jazz Pharmaceuticals ↗
Within the last quarter, Jazz Pharmaceuticals (NASDAQ:JAZZ) has observed the following analyst ratings: 
Via Benzinga
News headline image
Jazz Pharmaceuticals Announces Q3 2022 Financial Results, Raises Total Revenue Guidance ↗
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) announced its financial results late Wednesday for the third quarter of 2022 and raised the mid-point of 2022 total revenue guidance. 
Via Benzinga
News headline image
Why Axsome Therapeutics Stock Slipped Today ↗
Investors traded out of the company following the latest earnings release, but only to a modest degree. 
Via The Motley Fool
News headline image
3 Top Healthcare Stocks to Buy for November ↗
Catalysts lie ahead for these promising stocks. 
Via The Motley Fool
News headline image
2 Marijuana Stocks That Are Set for a Comeback ↗
Don't overlook these top stocks when investing in the marijuana space. 
Via The Motley Fool
News headline image
Jazz Pharma's Zepzelca For Lung Cancer Flunked Confirmatory Trial, But FDA Will Not Pull Accelerated Approval ↗
A petition was filed requesting that the FDA initiate proceedings to withdraw approval of all medications containing lurbinectedin, currently marketed under the brand Zepzelca by Jazz Pharmaceuticals... 
Via Benzinga
News headline image
Analyst Moves To Sidelines After Jazz Pharma Deal Shifts Zymeworks To Early Stage Pipeline ↗
 
Via Benzinga
News headline image
Why Is Zymeworks (ZYME) Stock Up Today? ↗
Zymeworks (ZYME) stock is climbing higher on Wednesday after the company signed a licensing agreement with Jazz Pharmaceuticals (JAZZ). 
Via InvestorPlace
News headline image
Jazz Obtains Exclusive Rights To Zymeworks' Cancer Candidate In Almost $2B Biobuck Deal ↗
 
Via Benzinga
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.